• 应用纪要

Bupropion

Bupropion

  • Waters Corporation

This is an Application Brief and does not contain a detailed Experimental section.

Abstract

This application brief demonstrates analysis of bupropion.

Introduction

The compound analyzed in this study is bupropion (USP Tailing Factor - 1.05).

Experimental

HPLC Method

Column:

Symmetry C8, 3.9 x 150 mm, 5 μm

Guard column:

Sentry Guard Column, 3.9 x 20 mm, 5 μm

Part number:

Column - WAT046970, Guard - WAT054250

Mobile phase:

20 mM potassium phosphate, pH 7.0/methanol 35:65

Flow rate:

1.0 mL/min

Injection volume:

10 μL of 20 μg/mL sample

Detection:

UV @ 254 nm

Results and Discussion

Featured Products

WA31763.43, June 2003

返回顶部 返回顶部